ArticlePolymers2023
Multi-Material Additive Manufacturing of High Temperature Polyetherimide (PEI)-Based Polymer Systems for Lightweight Aerospace Applications.
Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Additive Manufacturing of High-Performance Polymers for Extreme Environments.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Functional Materials for Additive Manufacturing: Materials Design, Processing, and Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Advances in Forming Processes of Carbon Fiber-Reinforced Thermoplastic Composites: From Material Challenges to Interface Engineering.Materials (Basel, Switzerland) · 2026Review
- Extrudability, printability, and strain rate sensitivity metrics of lightweight thermoplastic polyimide (PI) in material extrusion (MEX) additive manufacturing.RSC advances · 2025Article
- Composite Filament Materials for 3D-Printed Drone Parts: Advancements in Mechanical Strength, Weight Optimization and Embedded Electronics.Materials (Basel, Switzerland) · 2025Review
- High-Performance Polymer Blends: Manufacturing of Polyetherimide (PEI)-Polycarbonate (PC)-Based Filaments for 3D Printing.Polymers · 2024Article
- Nanomaterials Reinforced Polymer Filament for Fused Deposition Modeling: A State-of-the-Art Review.Polymers · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid innovations in 3-D printing technology have created a demand for multifunctional composites. Advanced polymers like amorphous thermoplastic polyetherimide (PEI) can create robust, lightweight, and efficient structures while providing high-temperature stability. This work manufactured ULTEM, a PEI-based polymer, and carbon-fiber-infused ULTEM multi-material composites with varying layering patterns (e.g., AAABBB vs. ABABAB) using fused filament fabrication (FFF). The microstructure of fractured surfaces and polished cross-sections determined that the print quality of layers printed closer to the heated bed was higher than layers closer to the top surface, primarily due to the thermal insulating properties of the material itself. Mechanical properties of the multi-material parts were between those of the single-material parts: an ultimate tensile strength and elastic modulus of 59 MPa and 3.005 GPa, respectively. Multi-material parts from the same filaments but with different layering patterns showed different mechanical responses. Prints were of higher quality and demonstrated a higher elastic modulus (3.080 GPa) when consecutive layers were printed from the same filament (AAABBB) versus parts with printed layers of alternating filaments (ABABAB), which showed a higher ultimate strength (62.04 MPa). These results demonstrate the potential for creatively designing multi-material printed parts that may enhance mechanical properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.